Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Flaherty

Showing results (201-210 of 242) with videos related to

Pageof 25
Sort By:
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
A Quantitative Imaging Measure of Progressive Pulmonary FibrosisJennifer M Wang, Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.
Annals of the American Thoracic Society|June 23, 2017
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine LearningDaniel G Pankratz, Yoonha Choi, Urooj Imtiaz, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
The New England Journal of Medicine|May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisSteven D Nathan, Peter Smith, Chunqin Deng, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
American Journal of Respiratory and Critical Care Medicine|February 22, 2019
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary FibrosisDavid N O'Dwyer, Shanna L Ashley, Stephen J Gurczynski, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
Pageof 25

Showing results (201-210 of 242) with videos related to

Sort By:
Pageof 25
Annals of the American Thoracic Society|August 11, 2020
The Pulmonary Fibrosis Foundation Patient Registry. Rationale, Design, and MethodsBonnie R Wang, Rex Edwards, Elizabeth A Freiheit, et al.
Cell Reports. Medicine|January 14, 2022
Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptorsTamara Muliaditan, Leena Halim, Lynsey M Whilding, et al.
JAMA|May 11, 2021
Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical TrialFernando J Martinez, Eric Yow, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|July 18, 2025
A Quantitative Imaging Measure of Progressive Pulmonary FibrosisJennifer M Wang, Ayodeji Adegunsoye, Janelle Vu Pugashetti, et al.
Annals of the American Thoracic Society|June 23, 2017
Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine LearningDaniel G Pankratz, Yoonha Choi, Urooj Imtiaz, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2024
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical TrialLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
The New England Journal of Medicine|May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary FibrosisSteven D Nathan, Peter Smith, Chunqin Deng, et al.
Scientific Reports|October 17, 2019
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation GenesNancy Casanova, Tong Zhou, Manuel L Gonzalez-Garay, et al.
American Journal of Respiratory and Critical Care Medicine|February 22, 2019
Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary FibrosisDavid N O'Dwyer, Shanna L Ashley, Stephen J Gurczynski, et al.
The Lancet. Respiratory Medicine|August 14, 2018
Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trialGanesh Raghu, Carlos A Pellegrini, Eric Yow, et al.
Pageof 25